WeVote

Bill

Bill

A 645

Authorizes the presence of epinephrine auto-injector devices on pre-school premises

2025 Regular Session Introduced by Linda Rosenthal

Authorizes epinephrine auto-injectors to be kept on preschool premises to rapidly treat anaphylaxis, benefiting students with severe allergies and on-site staff.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · A 645

Summary of Assembly Bill A 645

Overview

Bill A 645 is a New York Assembly measure titled “Authorizes the presence of epinephrine auto-injector devices on pre-school premises.” The bill aims to authorize pre-schools to have epinephrine auto-injector (EAI) devices on site to respond to allergic emergencies.

What the bill would do

  • Establishes authorization for the presence of epinephrine auto-injector devices on pre-school premises.
  • The language indicates a focus on enabling access to EAIs within pre-school settings to address anaphylaxis emergencies quickly. (Note: the full text is not provided here, so specific requirements such as storage protocols, staff training, or liability protections are not detailed in this summary.)

Who would be affected

  • Pre-school facilities and administrators who operate early childhood programs.
  • School staff and caregivers responsible for student health and safety.
  • Students with severe allergies or risk of anaphylaxis who might benefit from rapid access to EAIs.

Legislative status and timeline

  • Introduced: January 8, 2025.
  • Status: REFERRED TO HEALTH (New York Assembly Health Committee).
  • Legislative actions listed:
    • 2025-01-08: REFERRED TO HEALTH (twice listed in the record).
  • Sponsor: Linda Rosenthal (primary).

Related legislation

  • Related bills from prior sessions:
    • A 3821 (prior-session)
    • A 333 (prior-session)
  • Senate companion bills:
    • S 7166 (companion) [listed twice, indicating a companion in the Senate]

Key considerations and notes

  • The summary here reflects the central stated purpose: to authorize EAIs on pre-school premises. Specific provisions (e.g., storage, accessibility, training requirements, parental consent, or liability protections) are not provided in the available information.
  • No fiscal impact or implementation timeline is included in the provided materials.
  • As the bill is in the Health Committee, subsequent amendments or committee reports could shape the final provisions.

Next steps for readers

  • Monitor the Health Committee process for amendments or accompanying language.
  • Review the bill’s full text when available to understand any operational requirements, funding, or regulatory safeguards.
  • Consider related bills (A 3821, A 333, S 7166) for a fuller picture of how this proposal interacts with ongoing or similar legislation.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.